Calpains and muscular dystrophies

International Journal of Biochemistry and Cell Biology

Volumn 32, Issue 1, 2000, Pages 1-5

  Tidball, James G ^a   Spencer, Melissa J ^a  

^a Duchenne Muscular Dystrophy Res C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN;

ANIMAL MODEL; ARTICLE; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; GENE MUTATION; LIMB GIRDLE MUSCULAR DYSTROPHY; MOUSE; MUSCLE TISSUE; MUSCULAR DYSTROPHY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

NON-PROGRAMMATIC;

ANIMALS; BINDING SITES; CALCIUM; CALPAIN; DISEASE MODELS, ANIMAL; DYSTROPHIN; HUMANS; MUSCULAR DYSTROPHIES;

ANIMALIA;

EID: 0033988650     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(99)00095-3     Document Type: Article

References (15)

1. Croall D.E., Demartino G.N. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol. Rev. 71:1991;813-847.
2. Hathaway D.R., Werth D.K., Haeberle J.R. Limited autolysis reduces the calcium requirement of a smooth muscle calcium-activated protease. J. Biol. Chem. 257:1982;9072-9077.
3. Sorimachi H., Suzuki K. Sequence comparison among muscle-specific calpain, p94, and calpain subunits. Biochim. Biophys. Acta. 55:(62):1992.
4. Sorimachi H., Kinbara K., Kimura S., Takahashi M., Ishiura S., Sasagawa N., Sorimachi N., Shimada H., Tagawa K., Maruyama K., Suzuki K. Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence. J. Biol. Chem. 270:1995;31,158-31,162.
5. Carafoli E., Molinari M. Calpain: a protease in search of a function? Biochem. Biophys. Res. Commun. 247:1998;193-203.
6. Mellgren R.L. Calcium-dependent protease: an enzyme system active at cellular membranes. FASEB J. 1:1987;110-115.
7. 2+ requirement and heterodimer stability in m-calpain. J. Biol. Chem. 272:1997;11,268-11,275.
8. Baki A., Tompa P., Alexa A., Molnar O., Friedrich P. Autolysis parallels activation of μ-calpain. Biochem. J. 318:1996;897-901.
9. Michetti M., Salamino F., Melloni E., Pontremoli S. Reversible inactivation of calpain isoforms by nitric oxide. Biochem. Biophys. Res. Commun. 207:1995;1009-1014.
10. Bodensteiner J.B., Engel A.G. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology. 28:1978;439-446.
11. Spencer M.J., Croall D.E., Tidball J.G. Calpains are activated in necrotic fibers from mdx dystrophic mice. J. Biol. Chem. 270:1995;10,909-10,914.
12. Spencer M.J., Tidball J.G. Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice. Exp. Cell Res. 226:1996;264-272.
13. Richard I., Broux O., Allamand V., Fougerousse F., Chiannilkulchai N., Bourg N., Brenguier L., Devaud C., Pasturaud P., Roudaut C., Hillaire D., Passos-Bueno M., Zatz M., Tischfield J.A., Fardeau M., Jackson C.E., Cohen D., Beckmann J.S. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell. 81:1995;27-40.
14. Baghdiguian S., Martin M., Richard I., Pons F., Astier C., Bourg N., Hay R.T., Chemaly R., Halaby G., Loiselet J., Anderson L.V.B., Lopez de Munain A., Fardeau M., Mangeat P., Beckmann J.S., Lefranc G. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IκBa/NF-κB pathway in limb-girdle muscular dystrophy type 2A. Nature Medicine. 5:1999;503-511.
15. Ono Y., Shimada H., Sorimachi H., Richard I., Saido T.C., Beckmann J.S., Ishiura S., Suzuki K. Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J. Biol. Chem. 273:1998;17,073-17,078.